SEC Form 4 · accession 0001213529-17-000003
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Peter Walker
Director
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 4, 2017 | M | 9,478 | — | A | 73,178 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 4, 2017 | M | 9,478 | D | — | — | Common Stock | 9,478 | 0 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2On May 4, 2016, the reporting person was granted 9,478 restricted stock units, 100% of which vested on the one year anniversary of the date of grant, May 4, 2017.